Evidence map›Paper›PMID 42110614›Full record

ArticleArchives of medical science : AMS2026

The rare glucose response curve during oral glucose tolerance tests in pregnant Chinese women and its association with preterm birth.

Ya Xi, Binbin Yin, Jinghua Zhang, Yongying Bai

Abstract read
In one paragraph

Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ya XiDepartment of Central Laboratory, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
Binbin YinDepartment of Clinical Laboratory, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jinghua ZhangDepartment of Clinical Laboratory, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yongying BaiDepartment of Clinical Laboratory, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to investigate the rare glucose response curve during oral glucose tolerance tests (OGTTs) in pregnant Chinese women and its association with preterm birth. Material and methods: A total of 26,092 pregnant women were included in this study and categorized into two groups based on the shape of their glucose response curve during OGTTs conducted at 24-28 weeks of gestation. The curves were classified as either monophasic (MPh) or incessant increase (IIn). Logistic regression analysis was utilized to examine the association between these shapes and the risk of preterm birth. Additionally, we explored the relationship between these shapes and preterm birth across various factors including gestational diabetes mellitus (GDM) status, maternal age, preconception body mass index (BMI), and gestational weight gain (GWG). Results: The most prevalent OGTT curve observed was MPh (85.54%), followed by IIn (14.46%). Compared to the majority MPh group, curves with IIn had a higher rate of preterm birth ( Conclusions: This study establishes a significant correlation between the rare glucose response curve and the risk of preterm birth. Identifying IIn curves as an unfavorable factor for preterm birth, particularly among women with varying maternal ages, BMI, and GWG, holds substantial potential value for personalized risk assessment and intervention strategies.

Indexed as

glucose response curveincessant increasemonophasicoral glucose tolerance testpreterm birth

Identifiers

PMID42110614
PMCPMC13154745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.